Calamos Bitcoin Structured Alt Protection ETF - October
CBOO · ETF
About CBOO
- Issuer
- Calamos
- Expense ratio
- 0.69%
- Assets under management
- $6.11M
- Inception
- Oct 7, 2025
- Asset class
- Alternatives
- Website
- calamos.com
CBOO key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 3.34K
- Volume
- 7
- Open price
- $24.32
- High today
- $24.29
- Low today
- $24.29
- 52 Week high
- $24.98
- 52 Week low
- $24.21
Calamos Bitcoin Structured Alt Protection ETF - October (CBOO) at a glance
Calamos Bitcoin Structured Alt Protection ETF - October (CBOO) last traded at $24.29, with a price-to-earnings ratio of 0.00.
Volume so far is 7 shares, below the average of 3.34K shares a day.
Over the past year Calamos Bitcoin Structured Alt Protection ETF - October has ranged from $24.21 to $24.98, and now sits 10% of the way up that range.
CBOO news
- Chandrima Sanyal
- Chandrima Sanyal
EXCLUSIVE: Calamos Bitcoin ETF Upside Tops 40%: Top Exec Reveals the Catch Investors Can’t Ignore
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.